Company Snapshot

Read it, Learn it and Do it for your investment Needs
Company News Details
Glenmark Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code: 532296 NSE Symbol: GLENMARK P/E : 35.29
ISIN Demat: INE935A01035 Div & Yield %: 0.11 EPS : 61.81
Book Value: 868.32 Market Cap (Rs. Cr.): 61,563.52 Face Value : 1
Glenmark Pharmaceuticals announces change in senior management Back
(07 Apr 2025)
Glenmark Pharmaceuticals has appointed Anurag Mantri as President (Senior Management Personnel) with effect from 07 April 2025.

Further, V.S. Mani, Executive Director & Global Chief Financial Officer of the Company has decided to step down with effect from 26 May 2025.

The candidature of Anurag Mantri to the office of Executive Director & Global Chief Financial Officer will be put up before Audit Committee, Nomination & Remuneration Committee and Board of the Company in the ensuing committee meetings/Board meeting for approval and once approved, he will then be appointed as Executive Director and Global Chief Financial Officer.